Results 151 to 160 of about 1,341 (183)
Game Changer or More of the Same? A Comparative Meta-analysis of Rezafungin and Caspofungin in Treating Candidemia and Invasive Candidiasis. [PDF]
Sarfraz Z +9 more
europepmc +1 more source
Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement. [PDF]
Cortegiani A +13 more
europepmc +1 more source
Stress-Activated Protein Kinase Pathways as Potential Targets for the Development of New Antifungals. [PDF]
Alonso-Monge R +2 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Early use of the novel antifungal rezafungin: a case series and literature review.
Journal of Antimicrobial ChemotherapyOBJECTIVES Rezafungin is a novel echinocandin with a unique structural configuration enabling weekly IV dosing. We report on early use of rezafungin in our outpatient parenteral antibiotic therapy (OPAT) service, reviewing indications, treatment regimens,
H. Davidson +5 more
semanticscholar +3 more sources
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix
Pharmacotherapy: The Journal of Human Pharmacology and Drug TherapyManagement of invasive fungal infections is challenging with growing antifungal resistance. Broad antifungal use has resulted in greater intrinsic and acquired resistance among Candida spp.
Benjamin A August, P. Kale-Pradhan
semanticscholar +3 more sources

